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Summary
More than 97% of achondroplasia cases are caused by
one of two mutations (G1138A and G1138C) in the
fibroblast growth factor receptor 3 (FGFR3) gene, which
results in a specific amino acid substitution,G380R. Spo-
radic cases of achondroplasia have been associated with
advanced paternal age, suggesting that these mutations
occur preferentially during spermatogenesis. We have
determined the parental origin of the achondroplasia
mutation in 40 sporadic cases. Three distinct 1-bp pol-
ymorphisms were identified in the FGFR3 gene, within
close proximity to the achondroplasia mutation site.
Ninety-nine families, each with a sporadic case of achon-
droplasia in a child, were analyzed in this study. In this
population, the achondroplasia mutation occurred on
the paternal chromosome in all 40 cases in which pa-
rental origin was unambiguous. This observation is con-
sistent with the clinical observation of advanced paternal
age resulting in new cases of achondroplasia and sug-
gests that factors influencing DNA replication or repair
during spermatogenesis, but not during oogenesis, may
predispose to the occurrence of the G1138 FGFR3
mutations.
Introduction
Achondroplasia (MIM 100800) is the most common
form of dwarfism in humans. The disorder is inherited
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in an autosomal dominant manner, with full penetrance.
Two mutations, G1138A and G1138C, in exon 10 of
the FGFR3 gene result in a specific amino acid substi-
tution (G380R) (Rousseau et al. 1994; Shiang et al.
1994) and account for more than 97% of all reported
cases (Bellus et al. 1995a). On the basis of the incidence
of achondroplasia, FGFR3 nucleotide 1138 is among the
most highly mutable single nucleotides known in the
human genome. Specific FGFR3 mutations also have
been identified in disorders related to achondroplasia,
including thanatophoric dysplasia types I and II (Ta-
vormina et al. 1995; Rousseau et al. 1996), hypochon-
droplasia (Bellus et al. 1995b), and severe achondropla-
sia with developmental delay and acanthosis nigricans
dysplasia, a recently described skeletal dysplasia (Fran-
comano et al. 1996; G. A. Bellus, M. J. Bamshad, and
C. A. Francomano, unpublished data). In addition,
FGFR3 mutations have been identified in several cran-
iofacial disorders, including nonsyndromic craniosynos-
tosis and Crouzon syndrome with acanthosis nigricans
(Meyers et al. 1995; Bellus et al. 1996).
Sporadic cases of achondroplasia and other dominant
genetic disorders have been associated with advanced
paternal age, suggesting that these mutations occur pref-
erentially during spermatogenesis (Penrose 1957;
Thompson et al. 1986). Using single-base-pair poly-
morphisms in the FGFR3 gene that are proximate to the
site of the achondroplasia mutation, we have determined
the parental origin of the achondroplasia mutation in
40 sporadic cases. Heteroduplex analysis was used to
screen for FGFR3 intron polymorphisms, identifying
polymorphisms in FGFR3 introns 9 and 10. DNA from
99 families with sporadic occurrences of achondroplasia
was analyzed for heterozygosity of these polymor-
phisms, with informative probands heterozygous for at
least one of the polymorphisms. The amplification-re-
fractory mutation system (ARMS) (Moloney et al. 1996)
or sequencing was used to determine the phase of the
polymorphism, together with the achondroplasia mu-
tation or normal allele, in the probands. Determination
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Table 1
FGFR3 Oligonucleotide Primer Sequences
Primera Location Sequence
CD5-F Exon 9 5′-GGTTTTCTCATCACTCTGCG-3′
1138wt-R Exon 10 5′-GAACAGGAAGAAGCCCACCGC-3′
1138mut-R Exon 10 5′-GAACAGGAAGAAGCCCACCGT-3′
1138wt-F Exon 10 5′-ATGCAGGCATCCTCAGCTAGG-3′
1138mut-F Exon 10 5′-ATGCAGGCATCCTCAGCTAGA-3′
int10-R Exon 11 5′-GGTGTGTTGGAGCTCATGG-3′
int10-F Exon 10 5′-CCACCGTGCACAAAGATCTC-3′
961-F Exon 9 5′-CTGCCTGGCGGGCAATTCTA-3′
DT-R Exon 10 5′-GGAGATCTTGTGCACGGTGG-3′
DT-F Exon 10 5′-AGGAGCTGGTGGAGGCTGA-3′
1395-R Exon 11 5′-GCTCGAGCTCGGAGACATTG-3′







a F  forward, R  reverse, wt  wild type, and mut  mutant.
Figure 1 FGFR3 achondroplasia mutant and wild-type allele-specific oligonucleotide primers, designed to create a mismatch at the
nucleotide adjacent to the 3′ nucleotide, with the 3′ nucleotide corresponding to FGFR3 nucleotide 1138, the base mutated in the common
achondroplasia mutation analyzed in this study. The normal-allele PCR primers (1138wt-F and 1138wt-R) contained the wild-type nucleotide
G (or C on the reverse primer) as the 3′ base, maximizing the mismatch with the mutant allele. The mutant-allele PCR primers (1138mut-F
and 1138mut-R) contain the achondroplasia-mutation nucleotide A (or T on the reverse primer) as the 3′ base, maximizing the mismatch with
the normal allele.
of the polymorphic variant status in the parents allowed
the identification of the parent from whom the mutant
allele had been inherited. This analysis revealed that the
achondroplasia mutation occurred on the paternal chro-
mosome in all 40 informative probands. The paternal
origin of the mutant achondroplasia allele suggests that
factors influencing DNA replication or repair during
spermatogenesis, but not during oogenesis, may predis-
pose to the occurrence of achondroplasia.
Subjects and Methods
Subjects
Ninety-nine achondroplasia families were ascertained,
with informed consent, by genetics clinics at various lo-
cations in the United States, England, France, Finland,
and Poland. Each family consisted of one affected child,
with both parents being of average stature. In 97 fam-
ilies, the proband had the G1138A achondroplasia mu-
tation within FGFR3 exon 10, whereas the other 2 of
the 99 probands were heterozygous for the G1138Cmu-
tation. As far as we know, none of the families are related
to each other. Paternal and maternal ages at the time of
conception or birth of the proband were available for
39 and 37 of the 40 informative families, respectively.
The mean paternal and maternal ages in these families
were, respectively, and35.58 7.18 30.98 4.21
years.
Identification of Polymorphic Variants
Since the recurrent achondroplasia mutation is in exon
10 of the FGFR3 gene, regions of the gene that are close
to this site were examined for polymorphisms. Primer
pairs (int10-F and int10-R, 961-F and DT-R, or DT-F
and 1395-R) (table 1) were used to amplify FGFR3 in-
tron 9 or FGFR3 intron 10. Polymorphisms were iden-
tified by either SSCP or heteroduplex analysis and/or by
sequencing. Primers 961-F, I9A-F, and I9B-F were used
as sequencing primers for intron 9, and primers 1395-
R and I10B-R were used to sequence intron 10. Se-
quencing was performed either directly, by use of Dyna-
beads M-280 streptavidin (Dynal) (Thein and Hinton
1991), or by use of an ABI 377 automated DNA se-
quencer (Applied Biosystems).
Analysis of the Polymorphic Sites
Polymorphisms that altered a restriction site were an-
alyzed by means of the ARMS method (Moloney et al.
1996). In brief, in the probands, allele-specific PCR re-
actions were designed to amplify an FGFR3 gene region
that included both the site of the polymorphism and the
site of the common achondroplasia mutation. Allele-spe-
cific PCR was performed on either the mutant or normal
chromosome, by means of oligonucleotide primers spe-
cific for either the normal allele (1138 wt-F or 1138wt-
R) or the achondroplasia allele (1138mut-F or 1138mut-
R), and the appropriate corresponding primer (CD5-F
or int10-R) (table 1). Allele-specific primers were de-
signed to create a mismatch at the nucleotide adjacent
to the 3′ nucleotide, with the 3′ nucleotide corresponding
to FGFR3 nucleotide 1138 (Kwok et al. 1990) (fig. 1).
The normal-allele PCR primers (1138wt-F and 1138wt-
R) contained the wild-type nucleotide G (or C, on the
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Figure 2 PmlI (A) and PflMI (B) restriction digestion of allele-
specific PCR products, as recommended by the manufacturer. The sizes
of products of restriction digestion are shown. Analyses of four families
are presented. Allele-specific PCR of genomic DNA was performed
with either a normal-sequence (wt) oligonucleotide primer or an oli-
gonucleotide primer specific for the common achondroplasiamutation
(mut) (see fig. 1). The allele-specific primer used in the PCR reactions
is depicted as wt or mut. Reactions using DNA from the probands
are shown in lanes 2, 3, 6, and 7. PCR using genomic DNA from the
affected child was performed with either a wt oligonucleotide primer
or a mut primer. Parental DNAs are shown in lanes 1, 4, 5, and 8.
PCR of parental genomic DNA was performed with a wt primer. In
each case shown, the allele amplifying with the mut primer is inherited
from the father.
Figure 3 Potential paternal and maternal alleles. The PmlI polymorphism is used as an example. Allele-specific PCR was performed with
the proband’s genomic DNA, and digestion was performed with the appropriate restriction enzyme. If the proband was heterozygous for the
polymorphism, the parental DNAs were analyzed. The possible parental alleles and the parent from whom the mutant allele would be inherited
are shown. /  Homozygosity for the polymorphic sequence, /  homozygosity for the normal sequence, and /  heterozygosity
at the site.
reverse primer) as the 3′ base, maximizing the mismatch
to the mutant allele (fig. 1). The mutant-allele PCR prim-
ers (1138mut-F and 1138mut-R) contain the achondro-
plasia-mutation nucleotide A (or T, on the reverse
primer) as the 3′ base, maximizing the mismatch to the
normal allele (fig. 1). Digestion of the PCR product, with
either PflMI or PmlI, distinguished the phase of the poly-
morphism and mutation. For the intron 9 PflMI poly-
morphism, primers CD5-F and either 1138wt-R or
1138mut-R were used to amplify a 619-bp fragment (fig.
2). PCR of the intron 10 Pml1 polymorphism used prim-
ers int10-R and either 1138wt-F or 1138mut-F to am-
plify a 473-bp fragment (fig. 2). Parental genomic DNA
was amplified with either oligonucleotide primers CD5-
F and 1138wt-R or int10-R and 1138wt-F (table 1).
PCR reactions were performed with an initial denatur-
ation step of 2 min at 94C, followed by 35 cycles of
denaturation for 30 s at 94C, 30 s at an annealing
temperature of 60C or 62C, and an extension step for
30 s at 72C. After amplification, the PCR products
were digested with the appropriate restriction enzyme
(PmlI or PflMI) and were analyzed by agarose-gel
electrophoresis.
The polymorphic stretch of guanosine residues was
analyzed by either of two methods: by direct sequencing
of PCR products or by cloning of the PCR products and
then sequencing (TA cloning; Invitrogen). Allele-specific
PCR was used to amplify probands’ genomic DNA cor-
responding to the normal or FGFR3 G1138A mutant
allele, by use of both primer 1138wt-R or primer
1138mut-R and the CD5-F corresponding primer (table
1). Products from amplifications using the allele-specific
primers were purified (Quiquick PCR Purification col-
umns; Qiagen) and were sequenced. Parental genomic
DNA was amplified by use of primers 1138wt-r and
CD5-F (table 1). PCR products were cloned into the
pCR-3 vector (Invitrogen), plasmid DNA was isolated,
and the insert was sequenced directly to determine the
phase of the polymorphic allele and the mutation.
Results
Determination of Polymorphisms
Three distinct polymorphisms were identified in the
FGFR3 gene, within close proximity to the achondro-
plasia mutation site—two in intron 9 and one in intron
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Figure 4 Analysis of 99 probands. A total of 21, 9, and 17
probands were heterozygous for the PmlI, PflMI, and poly(G) poly-
morphisms, respectively. From those heterozygous probands, respec-
tively, 19, 6, and 15 parental alleles were informative for the deter-
mination of the parental origin of the achondroplasia allele. In all 40
informative families, the mutant allele was inherited from the father.
Figure 5 Sequence analysis of FGFR3 intron 9 poly(G) poly-
morphism. Normal intron 9 sequence (A) contains a stretch of 11
consecutive guanosine residues, whereas the polymorphic sequence (B)
has a G deletion in this sequence.
10. The polymorphisms included a GrC transition to-
ward the 5′ end of intron 9, which created a PflMI site;
a CrT transversion in intron 10, which created a PmlI
site; and a single G deletion in a stretch of 11 consecutive
guanosine residues in intron 9. To determine the fre-
quency of the PflMI and PmlI polymorphisms in the
general population, chromosomes of normal individuals
were genotyped. Ten (4.5%) of 224 chromosomes car-
ried the PflMI polymorphism, and 30 (10.4%) of 288
chromosomes carried the PmlI polymorphism.
For a family to be informative for any polymorphism,
the proband must be heterozygous at the site (see results
discussed below), with only one parent heterozygous for
the polymorphism or both parents homozygous for op-
posing variants (fig. 3). Families in which the proband
was homozygous for all three polymorphisms or in
which both parents were heterozygous for the poly-
morphisms and in which the affected child also was het-
erozygous were noninformative. Ninety-one families
were genotyped for the PmlI polymorphism, 83 were
genotyped for the PflMI polymorphism, and 82 were
genotyped for the poly(G) variant. Most families were
typed for more than one polymorphism. Once an in-
formative polymorphism had been found, no further
analysis was done on that family.
Restriction Site–Polymorphism Analysis
ARMS was used to determine the inheritance pattern
of specific alleles within the achondroplasia families. Al-
lele-specific PCR was done with either the mutant chro-
mosome or the normal chromosome. Digestion of the
PCR product with either PflMI or PmlI distinguished
the phase of the polymorphism and mutation (fig. 2).
Twenty-one probands were heterozygous for the Pml I
polymorphism, and nine probands were heterozygous
for the PfllM1 polymorphism.
A fragment of genomic DNA containing the RFLP site
from the parents of these informative probands was am-
plified and digested with the appropriate restriction en-
zyme (fig. 2). Nineteen sets of parents were found to be
informative for the Pml I restriction-site polymorphism,
and six sets of parents were informative at the PflM1
site (figs. 3 and 4). In all 25 cases informative for the
restriction-site polymorphisms, the proband’s paternal
chromosome carried the achondroplasia mutation.
Poly(G) Polymorphism Analysis
Sequencing of the PCR products determined both het-
erozygosity for the poly(G) polymorphism (fig. 5) and
the phase of the polymorphism with respect to the
achondroplasia mutation. Seventeen probands were de-
termined to be heterozygous for the poly(G) polymor-
phism. Parents of these informative probands were geno-
typed at this site, and 15 sets of parents were found to
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be informative (fig. 4). In all 15 cases informative for
the poly(G) polymorphism, the proband’s paternal chro-
mosome carried the achondroplasia mutation.
Discussion
Achondroplasia, the most common form of dwarfism,
results predominantly from a specific mutation,
G1138A, in the FGFR3 gene, with 197% of achondro-
plasia cases resulting from this mutation (Bellus et al.
1995a). The germ-line frequency of this mutation is es-
timated as being 5.5–28 # 106, suggesting that it is
the most mutable base in the human genome (Bellus et
al. 1995a). Although this base change occurs in the con-
text of a CpG dinucleotide, suggesting a spontaneous
methylation-deamination mechanism for the generation
of the mutation, the exceptionally high mutation rate of
this nucleotide represents an intriguing biological
phenomenon.
Using the ARMS method (Moloney et al. 1996), as
well as allele-specific PCR followed by sequencing, we
identified the parental origin of the mutant allele in 40
informative families. We have shown that, for new cases
of achondroplasia, in the 40 informative families that
we analyzed, the mutated allele was inherited exclusively
from the father. Although this observation does not ex-
clude inheritance of the achondroplasia allele from the
mother, the incidence of the maternal allele carrying the
achondroplasia mutation is probably low.
The mean paternal age for the achondroplasts ana-
lyzed in this study was 35.86 years, suggesting an ad-
vanced paternal–age effect. Achondroplasia was the first
genetic disorder that was hypothesized to have a pater-
nal-age component (Penrose 1955). More recently, pa-
ternal age also has been shown to be involved in other
FGFR disorders, including thanatophoric dysplasia (Or-
ioli et al. 1995) and Crouzon, Pfeiffer (Risch et al. 1987),
and Apert syndromes (Moloney et al.1996). These are
all disorders in which a few specific mutations result in
occurrences of the disorder, raising the notion that the
FGFR genes are predisposed to mutations at specific nu-
cleotides, compared with what occurs in other genes.
Moloney et al. (1996) have demonstrated that, in 57
Apert syndrome families, the FGFR2 mutation arose
from the paternal chromosome. Prior to their study, it
had been observed that there was a tendency for the
parents of Apert syndrome babies to be older than av-
erage (Blank 1960; Erickson and Cohen 1974), with the
paternal age being more advanced than thematernal age.
This led to Apert syndrome being associated with a spe-
cific paternal-age effect, with the syndrome having a less
significant association with advanced maternal age.
However, this association between a paternal-age effect
and Apert syndrome was disputed, with the thought that
maternal age contributed ∼30% of the total effect (Risch
et al. 1987). The results reported by Moloney et al.
(1996) conclusively demonstrated that the parental-age
effect is due to the father and that the postulated ma-
ternal contribution is small.
Male germ cells divide, after puberty, every 16 d. Thus,
because of the significant number of meioses that they
undergo, these cells may accumulate errors with ad-
vancing age. The advanced paternal–age effect that we
have observed for new achondroplasia mutations sug-
gests that these mutations arise during spermatogenesis
in the unaffected father and that they neither are the
result of somatic mosaicism in one of the parents nor
occur postzygotically in the embryo, although we cannot
rule out these mechanisms for the development of mu-
tations that result in achondroplasia (Reiser et al. 1984).
However, the lack of familial recurrence of achondro-
plasia would argue against significant levels of germ-line
mosaicism, although there have been a few reports of
multiple affected children from families with normal par-
ents (Bowen 1974; Fryns et al. 1983; Reiser et al. 1984;
Philip et al. 1988). Germ-line mosaicism in one parent
is known to result in recurrence of other disorders, in-
cluding osteogenesis imperfecta, which has a recurrence
rate of ∼7% (Cole and Dalgleish 1995), and pseudo-
achondroplasia (Ferguson et al. 1997).
FGFR3 nucleotide 1138, the site of the common
achondroplasia mutation, occurs in the context of a CpG
dinucleotide, predisposing this nucleotide to mutations.
However, the abundance of the specific achondroplasia
mutation, compared with other mutations at CpG din-
ucleotides, remains to be explained (Sommer 1995). The
mutation rate for the G1138A achondroplasia mutation
is enhanced by a factor of 102–103, compared with mu-
tation rates at other CpG dinucleotides (Bellus et al.
1995a). It also is unclear why this particular mutation
occurs so much more frequently during spermatogenesis
than during oogenesis.
Finally, the high-frequency FGFR2 mutation that
causes Apert syndrome does not occur in the context of
a CpG dinucleotide (Moloney et al. 1996). Thus, despite
the observations that both Apert syndrome and achon-
droplasia mutations occur exclusively on the paternally
derived chromosome, the mechanism resulting in these
FGFR mutations may not be the same. It is likely that
other mechanisms, as yet unrecognized, are contributing
to the high rates of mutation at specific sites in FGFR
genes. We anticipate that studies aimed at dissecting the
cause of high-frequency FGFR mutations, including the
common achondroplasia mutation, will add substan-
tially to our understanding of human mutational events.
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